Touyun Biotech Group Limited (HKG:1332)
Hong Kong · Delayed Price · Currency is HKD 0.1580
-0.0010 (-0.63%)
Sep 4, 2026, 3:59 PM HKT
Touyun Biotech Group Balance Sheet
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.39 | 5.06 | 16.32 | 34.49 | 128.1 | 60.2 |
Short-Term Investments | - | 2.52 | 3.87 | 7.53 | 6.2 | 5.91 |
Trading Asset Securities | - | - | 53.33 | 1.54 | 16.16 | 33.76 |
Cash & Short-Term Investments | 4.39 | 7.58 | 73.51 | 43.56 | 150.45 | 99.87 |
Cash Growth | -61.88% | -89.69% | 68.75% | -71.05% | 50.65% | -61.92% |
Accounts Receivable | 8.98 | 9.46 | 22.28 | 27.14 | 41.45 | 66.29 |
Other Receivables | 0.97 | 43.99 | 27.28 | 27.28 | 26.49 | 26.13 |
Receivables | 25.38 | 69.09 | 64.8 | 96.97 | 131.96 | 132.46 |
Inventory | 18.02 | 18.24 | 24.59 | 15.25 | 35.61 | 32.77 |
Prepaid Expenses | 50.42 | 3.44 | 4.21 | 2.87 | 3.99 | 3.12 |
Other Current Assets | - | - | 6.94 | 3.83 | - | - |
Total Current Assets | 98.21 | 98.35 | 174.05 | 162.48 | 322.01 | 268.22 |
Property, Plant & Equipment | 251.21 | 242.19 | 280.18 | 310.63 | 381.28 | 435.95 |
Long-Term Investments | 627.64 | 278.97 | 95.9 | 134.03 | 184.13 | 318.94 |
Other Intangible Assets | - | - | - | - | 0.28 | 0.66 |
Long-Term Deferred Charges | - | - | - | - | - | 0.97 |
Total Assets | 977.26 | 619.7 | 550.32 | 607.34 | 887.7 | 1,025 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8.84 | 7.81 | 12.53 | 17.96 | 28.32 | 37.88 |
Accrued Expenses | 21.97 | 20.2 | 18.89 | 16.91 | 15.49 | 12.15 |
Short-Term Debt | 83.24 | 99.05 | 99.36 | 94.39 | 284.35 | 388.87 |
Current Portion of Long-Term Debt | 474.37 | 409.74 | 339.32 | 164.89 | - | - |
Current Portion of Leases | 4.04 | 3.53 | 10.13 | 14.46 | 12 | 14.41 |
Current Income Taxes Payable | 0.17 | 0.17 | 0.17 | 0.51 | 4.14 | 2.17 |
Current Unearned Revenue | 6.47 | 5.56 | 22.16 | 18.88 | 17.18 | 23.48 |
Other Current Liabilities | 41.27 | 45.4 | 55.44 | 52.7 | 48.51 | 50.61 |
Total Current Liabilities | 640.38 | 591.45 | 557.98 | 380.71 | 410 | 529.56 |
Long-Term Debt | - | - | 26.81 | 191.45 | 191.29 | - |
Long-Term Leases | 3.7 | 0.35 | 6.17 | 14.1 | 2.9 | 8.12 |
Pension & Post-Retirement Benefits | 0.55 | 0.51 | - | - | - | - |
Total Liabilities | 644.64 | 592.31 | 590.96 | 586.27 | 604.19 | 537.68 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 112.24 | 112.24 | 112.24 | 112.24 | 112.24 | 112.24 |
Additional Paid-In Capital | - | 1,908 | 1,908 | 1,908 | 1,908 | 1,908 |
Retained Earnings | - | -2,098 | -2,137 | -2,061 | -1,801 | -1,608 |
Comprehensive Income & Other | 28.95 | 26.87 | 34.07 | 39.92 | 45.27 | 58.52 |
Total Common Equity | 141.19 | -51.1 | -83.2 | -0.85 | 263.96 | 469.92 |
Minority Interest | 191.44 | 78.49 | 42.56 | 21.92 | 19.55 | 17.13 |
Shareholders' Equity | 332.63 | 27.39 | -40.64 | 21.07 | 283.51 | 487.05 |
Total Liabilities & Equity | 977.26 | 619.7 | 550.32 | 607.34 | 887.7 | 1,025 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 565.36 | 512.68 | 481.78 | 479.3 | 490.55 | 411.41 |
Net Cash (Debt) | -560.97 | -505.09 | -408.27 | -435.74 | -340.1 | -311.54 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.20 | -0.18 | -0.15 | -0.16 | -0.12 | -0.11 |
Filing Date Shares Outstanding | 2,806 | 2,806 | 2,806 | 2,806 | 2,806 | 2,806 |
Total Common Shares Outstanding | 2,806 | 2,806 | 2,806 | 2,806 | 2,806 | 2,806 |
Working Capital | -542.17 | -493.1 | -383.93 | -218.23 | -87.99 | -261.34 |
Book Value Per Share | 0.05 | -0.02 | -0.03 | -0.00 | 0.09 | 0.17 |
Tangible Book Value | 141.19 | -51.1 | -83.2 | -0.85 | 263.68 | 469.26 |
Tangible Book Value Per Share | 0.05 | -0.02 | -0.03 | -0.00 | 0.09 | 0.17 |
Buildings | - | 168.17 | 175.81 | 174.32 | 167.34 | - |
Machinery | - | 133.63 | 169.74 | 175.68 | 175.55 | 77.24 |
Construction In Progress | - | - | 2.4 | 5.81 | 0.65 | 310.85 |
Leasehold Improvements | - | 4.47 | 5.19 | 5.41 | 5.33 | 5.37 |